Abbott Laboratories (ABT)

34.41

+0.02 (+0.06%)

Range	34.29 - 34.66
52 week	26.2039 - 34.6912
Open	34.39
Vol/Avg.	14,576,700

Mkt cap	54.391B
P/E	9.24
EPS	3.72
Book/share	17.09

Short ratio	1.00
PEG	1.43
EPS est.	0.45

Rare webinar exposes 1 new law that will kill
your wealth in 2013 unless you take action now...

ABT additional information

Loading ...

Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.

Trading Offers • Rare webinar exposes 1 new law that will kill your wealth in 2013 unless you take action now...		Special Offers • Download a free Options Fundamentals Podcast, from The Options Industry Council.

ABT Profile

•

Exchange

NYSE

•

Sector

Drugs

•

Industry

Drug Manufacturers - Major

•

Top Holders (By Fund)

American Funds Invmt Co of America 529E
American Funds Capital Inc Bldr 529B
American Funds Capital Inc Bldr R5
American Funds Capital Inc Bldr R4
American Funds Capital Inc Bldr R2
American Funds Capital Inc Bldr R1
American Funds Capital Inc Bldr F-1
American Funds Capital Inc Bldr C
American Funds Capital Inc Bldr B
American Funds Capital Inc Bldr A

•

Top Holders (By Family)

American Funds
Vanguard
Principal Funds
Wells Fargo Advantage
Columbia
Pioneer Investments
Aston
Jensen
BlackRock
Eaton Vance

•

Competitors

Johnson & Johnson
Boston Scientific
Medtronic
Merck & Company
Sanofi-Aventis SA

•

Executives

Mr. Miles D. White
Chairman
Chief Exec. Officer and Chairman of Exec. Committee
Mr. Thomas C. Freyman
Chief Financial Officer and Exec. VP of Fin.

Mr. Richard A. Gonzalez
Exec. VP of Pharmaceutical Products

Ms. Laura J. Schumacher
Exec. VP
Gen. Counsel and Sec.
Dr. John M. Leonard M.D.
Sr. VP of Pharmaceuticals
R&D

•

Index Membership

NYSE Composite

•

Employee Count

91,000